AVE 33.3% 0.2¢ avecho biotechnology limited

it`s the balance sheet stupid, page-11

  1. 5,794 Posts.
    lightbulb Created with Sketch. 735
    ""The market has probably worked out that the recent raising wasn`t enough, and the monkey is still there.""

    Seriously mutts ~ the price drops a cent with some trading action and you see it as all these people working out there is not enough money.

    Cash flow positive is the aim next year, that to me means that revenue generated exceeds revenue spent.
    You are assuming that a burn rate of 750K per month will conntinue and that no income will come in.
    With body shaper, elixia, le metier, mastitis starting to gain revenue the balance sheet may quickly come down to say 100K a month in the red, until eventually next year the tables turn positive.
    That also does not include any possible licensing income, or milestones that may soon be coming.

    Today was fairly predictable, what happens between now and body shaper launch is what really interests me.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $11.50K 4.335M

Buyers (Bids)

No. Vol. Price($)
63 101422109 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 20872825 7
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.